These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 25172053)
1. Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis. Weishaar KM; Thamm DH; Worley DR; Kamstock DA J Comp Pathol; 2014 Nov; 151(4):329-38. PubMed ID: 25172053 [TBL] [Abstract][Full Text] [Related]
2. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367 [TBL] [Abstract][Full Text] [Related]
3. Weishaar's classification system for nodal metastasis in sentinel lymph nodes: Clinical outcome in 94 dogs with mast cell tumor. Stefanello D; Gariboldi EM; Boracchi P; Ferrari R; Ubiali A; De Zani D; Zani DD; Grieco V; Giudice C; Recordati C; Caniatti M; Auletta L; Chiti LE J Vet Intern Med; 2024; 38(3):1675-1685. PubMed ID: 38426589 [TBL] [Abstract][Full Text] [Related]
4. Use of indirect computed tomography lymphangiography to determine metastatic status of sentinel lymph nodes in dogs with a pre-operative diagnosis of melanoma or mast cell tumour. Grimes JA; Secrest SA; Wallace ML; Laver T; Schmiedt CW Vet Comp Oncol; 2020 Dec; 18(4):818-824. PubMed ID: 32216019 [TBL] [Abstract][Full Text] [Related]
5. Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours. Miyagi H; Townsend KL; Ettinger AM; Russell DS; Colee JC; Newsom LE Vet Comp Oncol; 2024 Mar; 22(1):49-56. PubMed ID: 38043517 [TBL] [Abstract][Full Text] [Related]
6. The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study. Ferrari R; Marconato L; Buracco P; Boracchi P; Giudice C; Iussich S; Grieco V; Chiti LE; Favretto E; Stefanello D Vet Comp Oncol; 2018 Dec; 16(4):505-510. PubMed ID: 29893066 [TBL] [Abstract][Full Text] [Related]
7. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. Worley DR Vet Comp Oncol; 2014 Sep; 12(3):215-26. PubMed ID: 22958227 [TBL] [Abstract][Full Text] [Related]
8. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F; Gear R; Hoather T; Dobson J J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010). Baginski H; Davis G; Bastian RP J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of canine mast cell tumors. Pokorny E; Hecht S; Sura PA; LeBlanc AK; Phillips J; Conklin GA; Haifley KA; Newkirk K Vet Radiol Ultrasound; 2012; 53(2):167-73. PubMed ID: 22136427 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal lymph node step-sectioning for the identification of metastatic disease in canine mast cell tumor. Sabattini S; Faroni E; Renzi A; Ghisoni G; Rigillo A; Bettini G; Pasquini A; Zanardi S; Guerra D; Marconato L Vet Pathol; 2022 Sep; 59(5):768-772. PubMed ID: 35400236 [TBL] [Abstract][Full Text] [Related]
12. Ultrasound-guided cytology of spleen and liver: a prognostic tool in canine cutaneous mast cell tumor. Stefanello D; Valenti P; Faverzani S; Bronzo V; Fiorbianco V; Pinto da Cunha N; Romussi S; Cantatore M; Caniatti M J Vet Intern Med; 2009; 23(5):1051-7. PubMed ID: 19656285 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007). Hume CT; Kiupel M; Rigatti L; Shofer FS; Skorupski KA; Sorenmo KU J Am Anim Hosp Assoc; 2011; 47(1):37-44. PubMed ID: 21164163 [TBL] [Abstract][Full Text] [Related]
14. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M; Webster JD; Miller RA; Kaneene JB J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909 [TBL] [Abstract][Full Text] [Related]
15. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Ayl RD; Couto CG; Hammer AS; Weisbrode S; Ericson JG; Mathes L Vet Pathol; 1992 Sep; 29(5):386-90. PubMed ID: 1413405 [TBL] [Abstract][Full Text] [Related]
16. Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes. Chalfon C; Sabattini S; Finotello R; Faroni E; Guerra D; Pisoni L; Ciammaichella L; Vasconi ME; Annoni M; Marconato L J Small Anim Pract; 2022 Sep; 63(9):661-669. PubMed ID: 35733233 [TBL] [Abstract][Full Text] [Related]
17. Lymph node histology for the assessment of residual neoplastic disease in canine mast cell tumours: does the presence of metachromatic granules always identify mast cells? Ressel L; Finotello R Vet Comp Oncol; 2017 Dec; 15(4):1119-1121. PubMed ID: 27714908 [No Abstract] [Full Text] [Related]
18. The utility of staging in canine mast cell tumours. Warland J; Amores-Fuster I; Newbury W; Brearley M; Dobson J Vet Comp Oncol; 2014 Dec; 12(4):287-98. PubMed ID: 23240829 [TBL] [Abstract][Full Text] [Related]
19. Histologic grade has a higher-weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes. Guerra D; Faroni E; Sabattini S; Agnoli C; Chalfon C; Stefanello D; Del Magno S; Cola V; Grieco V; Marconato L Vet Comp Oncol; 2022 Sep; 20(3):551-558. PubMed ID: 35195937 [TBL] [Abstract][Full Text] [Related]
20. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Murphy S; Sparkes AH; Blunden AS; Brearley MJ; Smith KC Vet Rec; 2006 Mar; 158(9):287-91. PubMed ID: 16517820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]